Not Yet Recruiting
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
NCT07349641
- Conditions
- Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia, Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, +6 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Lyndon Baines Johnson General Hospital Houston, Texas, United States
- UT MD Anderson Cancer Center Houston, Texas, United States